日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Potential utility of albumin-bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitors

基于白蛋白-胆红素和体重指数的逻辑回归模型在预测接受免疫检查点抑制剂治疗的非小细胞肺癌肝转移患者的生存结果方面的潜在应用价值

期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000003385
Song, Lianxi; Xu, Qinqin; Zhong, Ting; Guo, Wenhuan; Lin, Shaoding; Jiang, Wenjuan; Wang, Zhan; Deng, Li; Huang, Zhe; Qin, Haoyue; Yan, Huan; Zhang, Xing; Tong, Fan; Zhang, Ruiguang; Liu, Zhaoyi; Zhang, Lin; Dong, Xiaorong; Li, Ting; Fang, Chao; Chen, Xue; Deng, Jun; Wang, Jing; Yang, Nong; Zeng, Liang; Zhang, Yongchang
免疫/内分泌
细胞生物学
肺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLC.

基于淋巴细胞亚群的非侵入性生物标志物可预测 EGFR-TKI 预处理的 EGFR 突变型 NSCLC 的免疫化疗疗效

期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2025.113211
Song Lianxi, Zeng Liang, Xu Qinqin, Li Yizhi, Guo Wenhuan, Lin Shaoding, Jiang Wenjuan, Wang Zhan, Deng Li, Huang Zhe, Qin Haoyue, Yan Huan, Zhang Xing, Tong Fan, Zhang Ruiguang, Liu Zhaoyi, Zhang Lin, Yu Juan, Yang Xue, Xia Yang, Dong Xiaorong, Zhang Gao, Yang Nong, Zhang Yongchang
细胞生物学
EGFR
发表日期：2025
文献求助 收藏

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China

帕博利珠单抗治疗MSI-H和TMB-H晚期实体瘤的临床疗效证据：来自中国三家癌症中心的研究结果

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03660-2
Yan, Huan; Song, Lianxi; Li, Yizhi; Xu, Qinqin; Guo, Wenhuan; Lin, Shaoding; Jiang, Wenjuan; Wang, Zhan; Deng, Li; Huang, Zhe; Qin, Haoyue; Zhang, Xing; Tong, Fan; Zhang, Ruiguang; Liu, Zhaoyi; Zhang, Lin; Yu, Juan; Dong, Xiaorong; Gong, Qian; Deng, Jun; Chen, Xue; Wang, Jing; Zhang, Gao; Yang, Nong; Zhang, Yongchang; Zeng, Liang
多发性硬化症
肿瘤免疫
肿瘤
发表日期：2024
文献求助 收藏

Development of a prognostic nomogram for advanced non-small cell lung cancer using clinical characteristics

利用临床特征构建晚期非小细胞肺癌预后列线图

期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2024.110910
Qin, Haoyue; Huang, Zhe; Yan, Huan; Song, Lianxi; Zeng, Liang; Xu, Qinqin; Guo, Wenhuan; Lin, Shaoding; Jiang, Wenjuan; Wang, Zhan; Deng, Li; Zhang, Xing; Tong, Fan; Zhang, Ruiguang; Liu, Zhaoyi; Zhang, Lin; Dong, Xiaorong; Yang, Nong; Zhang, Yongchang
肿瘤免疫
肺癌
细胞生物学
肿瘤
发表日期：2024
文献求助 收藏

Analysis of Baseline Molecular Factors Associated With the Risk of Central Nervous System Progression Among Alectinib-Treated Patients With ALK-Positive NSCLC

对接受阿来替尼治疗的ALK阳性非小细胞肺癌患者中枢神经系统进展风险相关的基线分子因素进行分析

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2024.100729
Song, Lianxi; Yan, Huan; Xu, Qinqin; Zhou, Chunhua; Liang, Juan; Lin, Shaoding; Zhang, Ruiguang; Yu, Juan; Xia, Yang; Yang, Nong; Zeng, Liang; Zhang, Yongchang
肺癌
肿瘤
肿瘤免疫
ALK
神经科学
细胞生物学
发表日期：2024
文献求助 收藏